Literature DB >> 10832572

Lay constructions of HIV and complementary therapy use.

D Pawluch1, R Cain, J Gillett.   

Abstract

This study examines the meanings that individuals with HIV attach to their use of complementary therapies. A qualitative analysis of 66 interviews completed between 1993 and 1998 showed that complementary therapies represent different things for these individuals--a health maintenance strategy, a healing strategy, an alternative to Western medicine, a way of mitigating the side-effects of drug therapies, a strategy for maximizing quality of life, a coping strategy, and a form of political resistance. We found that the meanings individuals ascribe to complementary therapies and the benefits they expect to derive from them are not idiosyncratic, but linked to social characteristics--sexuality, ethnocultural background, gender--and to beliefs about health and illness, values and experiences. We found as well that these meanings are neither mutually exclusive nor fixed. The therapies often appeal to individuals on different levels and their appeal may change over time.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10832572     DOI: 10.1016/s0277-9536(99)00450-5

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  16 in total

1.  Integrated medicine in the management of chronic illness: a qualitative study.

Authors:  Sarah B Brien; Felicity L Bishop; Kirsty Riggs; David Stevenson; Victoria Freire; George Lewith
Journal:  Br J Gen Pract       Date:  2011-02       Impact factor: 5.386

Review 2.  A review of the use of complementary and alternative medicine and HIV: issues for patient care.

Authors:  Ava Lorenc; Nicola Robinson
Journal:  AIDS Patient Care STDS       Date:  2013-09       Impact factor: 5.078

Review 3.  Complementary and alternative medicine use among HIV-positive people: research synthesis and implications for HIV care.

Authors:  Rae A Littlewood; Peter A Vanable
Journal:  AIDS Care       Date:  2008-09

4.  Alcohol consumption within the context of hepatitis C: a qualitative study of non-problematic drinkers.

Authors:  Eleanor Palo Stoller; Andrew J Hund; Noah J Webster; Carol E Blixen; Adam T Perzynski; Richard A McCormick; Stephanie W Kanuch; Neal V Dawson
Journal:  Alcohol Alcohol       Date:  2006-07-19       Impact factor: 2.826

5.  Health practices and vaginal microbicide acceptability among urban black women.

Authors:  Marian Reiff; Christine Wade; Maria T Chao; Fredi Kronenberg; Linda F Cushman
Journal:  J Womens Health (Larchmt)       Date:  2008-10       Impact factor: 2.681

6.  What complementary and alternative medicine practitioners say about health and health care.

Authors:  Bruce Barrett; Lucille Marchand; Jo Scheder; Diane Appelbaum; Mary Beth Plane; Joseph Blustein; Rob Maberry; Christina Capperino
Journal:  Ann Fam Med       Date:  2004 May-Jun       Impact factor: 5.166

7.  Use of complementary and alternative medicine in inner-city persons with or at risk for HIV infection.

Authors:  Felise B Milan; Julia H Arnsten; Robert S Klein; Ellie E Schoenbaum; Galina Moskaleva; Donna Buono; Mayris P Webber
Journal:  AIDS Patient Care STDS       Date:  2008-10       Impact factor: 5.078

8.  Use of complementary and alternative medicines and supplements by Mexican-origin patients in a U.S.-Mexico border HIV clinic.

Authors:  Michele G Shedlin; Joyce K Anastasi; Carlos U Decena; José O Rivera; Oscar Beltran; Kaitlyn Smith
Journal:  J Assoc Nurses AIDS Care       Date:  2012-11-02       Impact factor: 1.354

9.  The potential of complementary and alternative medicine in promoting well-being and critical health literacy: a prospective, observational study of shiatsu.

Authors:  Andrew F Long
Journal:  BMC Complement Altern Med       Date:  2009-06-18       Impact factor: 3.659

10.  Incommensurable worldviews? Is public use of complementary and alternative medicines incompatible with support for science and conventional medicine?

Authors:  Paul Stoneman; Patrick Sturgis; Nick Allum; Elissa Sibley
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.